EJNMMI Research

Table 4 Tumour-to-normal tissue ratios of ¹⁷⁷Lu-SS-03 and ^99mTc-SS-04 after 1, 4, and 24 h of administration in nude mice bearing HEK293-rsst2 tumour xenografts

From: The tetraamine chelator outperforms HYNIC in a new technetium-99m-labelled somatostatin receptor 2 antagonist

	¹⁷⁷Lu-SS-03			^99mTc-SS-04
	1 h	4 h	24 h	1 h	4 h	24 h
Tumour/blood	41.3	150.5	360.9	25.5	218.1	981.3
Tumour/liver	7.9	18.1	55.8	6.6	9.2	17.4
Tumour/kidney	1.56	1.86	3.58	0.95	1.85	5.16
Tumour/muscles	109.5	259.3	372.1	73.6	382.1	616.7
Tumour/bone	5.7	11.5	21.1	14.9	51.3	74.1

Back to article page